A detailed history of Central Pacific Bank Trust Division transactions in Haemonetics Corp stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 2,765 shares of HAE stock, worth $196,757. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,765
Previous 2,109 31.1%
Holding current value
$196,757
Previous $174 Million 27.38%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 02, 2024

BUY
$72.45 - $91.58 $47,527 - $60,076
656 Added 31.1%
2,765 $222 Million
Q2 2024

Jul 30, 2024

BUY
$81.24 - $97.37 $38,020 - $45,569
468 Added 28.52%
2,109 $174 Million
Q1 2024

May 02, 2024

BUY
$71.24 - $85.35 $116,904 - $140,059
1,641 New
1,641 $139 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.65B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Central Pacific Bank Trust Division Portfolio

Follow Central Pacific Bank Trust Division and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Pacific Bank Trust Division, based on Form 13F filings with the SEC.

News

Stay updated on Central Pacific Bank Trust Division with notifications on news.